Membrane Pharmaceuticals

Membrane Pharmaceuticals is a biotechnology company focused on developing a proprietary platform for cell-surface anchored therapeutics. The company's core technology, the Membrane-Anchor Technology (M-Platform), allows therapeutic proteins like cytokines to be tethered directly to the cell membrane. This localization is designed to concentrate the drug's activity at the site of disease while preventing systemic circulation and the associated off-target toxicities. Their lead programs focus on neuroinflammatory conditions, utilizing anchored versions of Interleukin-10 (IL-10). By improving the safety profile of potent signaling molecules, the company aims to provide more effective treatments for chronic inflammatory diseases and acute neurological injuries.